tiprankstipranks
Trending News
More News >
Kaken Pharmaceutical Co (JP:4521)
OTHER OTC:4521
Japanese Market

Kaken Pharmaceutical Co (4521) Financial Statements

Compare
0 Followers

Kaken Pharmaceutical Co Financial Overview

Kaken Pharmaceutical Co's market cap is currently ¥147.68B. The company's EPS TTM is ¥19.03; its P/E ratio is 215.05; and it has a dividend yield of 4.16%. Kaken Pharmaceutical Co is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ¥24.79. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 94.03B¥ 72.04B¥ 72.98B¥ 76.03B¥ 74.98B
Gross Profit¥ 58.26B¥ 38.54B¥ 39.56B¥ 41.58B¥ 40.91B
Operating Income¥ 21.04B¥ 9.51B¥ 8.00B¥ 17.06B¥ 17.79B
EBITDA¥ 22.02B¥ 12.57B¥ 9.40B¥ 16.38B¥ 20.99B
Net Income¥ 13.95B¥ 8.03B¥ 5.44B¥ 9.55B¥ 13.40B
Balance Sheet
Cash & Short-Term Investments¥ 70.08B¥ 65.32B¥ 74.26B¥ 74.62B¥ 77.31B
Total Assets¥ 190.42B¥ 171.62B¥ 166.33B¥ 165.18B¥ 163.33B
Total Debt¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B¥ 3.85B
Net Debt¥ -50.24B¥ -46.77B¥ -55.71B¥ -57.17B¥ -59.86B
Total Liabilities¥ 37.78B¥ 27.87B¥ 29.49B¥ 26.86B¥ 27.08B
Stockholders' Equity¥ 152.63B¥ 143.75B¥ 136.26B¥ 137.75B¥ 136.26B
Cash Flow
Free Cash Flow¥ 25.64B¥ 410.00M¥ 7.05B¥ 10.08B¥ 12.09B
Operating Cash Flow¥ 29.78B¥ 2.58B¥ 9.25B¥ 13.34B¥ 14.38B
Investing Cash Flow¥ -19.65B¥ -5.85B¥ -2.63B¥ -7.89B¥ -1.64B
Financing Cash Flow¥ -5.37B¥ -5.66B¥ -6.99B¥ -8.13B¥ -8.75B
Currency in JPY

Kaken Pharmaceutical Co Earnings and Revenue History

Kaken Pharmaceutical Co Debt to Assets

Kaken Pharmaceutical Co Cash Flow

Kaken Pharmaceutical Co Forecast EPS vs Actual EPS